These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36038903)

  • 21. Status of antimicrobial stewardship programmes in Korean hospitals including small to medium-sized hospitals and the awareness and demands of physicians: a nationwide survey in 2020.
    Lee MJ; Moon SM; Kim B; Park SY; Park JY; Koo H; Lee H; Song KH; Lee H; Park JS; Lee MS; Choi SM; Kim CJ; Chang HH; Kim TH; Park SH; Kim ES; Kim HB;
    J Glob Antimicrob Resist; 2021 Sep; 26():180-187. PubMed ID: 34153526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial Resistance (AMR) - A Threat Continues Emerging in Covid-19 Pandemic & Role of Antimicrobial Stewardship Programmes (ASPs).
    Nasrumminallah M; Babar N; Qasim M
    J Pak Med Assoc; 2022 Oct; 72(10):2140-2141. PubMed ID: 36661022
    [No Abstract]   [Full Text] [Related]  

  • 23. Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings.
    Morris AM; Rennert-May E; Dalton B; Daneman N; Dresser L; Fanella S; Grant J; Keynan Y; Le Saux N; McDonald J; Shevchuk Y; Thirion D; Conly JM
    Antimicrob Resist Infect Control; 2018; 7():104. PubMed ID: 30181869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients.
    Davis MW; McManus D; Koff A; Jaszczur GR; Malinis M; Dela Cruz C; Britto CJ; Price C; Azmy V; Kaman K; Gaston D; Early K; DeWitt M; Song JS; Ortiz C; Juthani-Mehta M; Topal JE
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1335-1337. PubMed ID: 32507113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antimicrobial stewardship programmes in acute-care hospitals in four European countries: A cross-sectional survey.
    Kallen MC; Binda F; Ten Oever J; Tebano G; Pulcini C; Murri R; Beovic B; Saje A; Prins JM; Hulscher MEJL; Schouten JA;
    Int J Antimicrob Agents; 2019 Sep; 54(3):338-345. PubMed ID: 31200022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19: Impact on prescribing and antimicrobial resistance.
    Ruiz-Garbajosa P; Cantón R
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):63-68. PubMed ID: 34598431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate risk perception for SARS-CoV-2 infection among Italian HCWs in the eve of COVID-19 pandemic.
    Riccò M; Vezzosi L; Balzarini F; Bragazzi NL
    Acta Biomed; 2020 May; 91(3):e2020040. PubMed ID: 32921735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
    Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
    J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
    Furukawa D; Graber CJ
    Clin Infect Dis; 2021 May; 72(10):e542-e544. PubMed ID: 32857832
    [No Abstract]   [Full Text] [Related]  

  • 30. The
    Sartelli M; Labricciosa FM; Barbadoro P; Pagani L; Ansaloni L; Brink AJ; Carlet J; Khanna A; Chichom-Mefire A; Coccolini F; Di Saverio S; May AK; Viale P; Watkins RR; Scudeller L; Abbo LM; Abu-Zidan FM; Adesunkanmi AK; Al-Dahir S; Al-Hasan MN; Alis H; Alves C; Araujo da Silva AR; Augustin G; Bala M; Barie PS; Beltrán MA; Bhangu A; Bouchra B; Brecher SM; Caínzos MA; Camacho-Ortiz A; Catani M; Chandy SJ; Jusoh AC; Cherry-Bukowiec JR; Chiara O; Colak E; Cornely OA; Cui Y; Demetrashvili Z; De Simone B; De Waele JJ; Dhingra S; Di Marzo F; Dogjani A; Dorj G; Dortet L; Duane TM; Elmangory MM; Enani MA; Ferrada P; Esteban Foianini J; Gachabayov M; Gandhi C; Ghnnam WM; Giamarellou H; Gkiokas G; Gomi H; Goranovic T; Griffiths EA; Guerra Gronerth RI; Haidamus Monteiro JC; Hardcastle TC; Hecker A; Hodonou AM; Ioannidis O; Isik A; Iskandar KA; Kafil HS; Kanj SS; Kaplan LJ; Kapoor G; Karamarkovic AR; Kenig J; Kerschaever I; Khamis F; Khokha V; Kiguba R; Kim HB; Ko WC; Koike K; Kozlovska I; Kumar A; Lagunes L; Latifi R; Lee JG; Lee YR; Leppäniemi A; Li Y; Liang SY; Lowman W; Machain GM; Maegele M; Major P; Malama S; Manzano-Nunez R; Marinis A; Martinez Casas I; Marwah S; Maseda E; McFarlane ME; Memish Z; Mertz D; Mesina C; Mishra SK; Moore EE; Munyika A; Mylonakis E; Napolitano L; Negoi I; Nestorovic MD; Nicolau DP; Omari AH; Ordonez CA; Paiva JA; Pant ND; Parreira JG; Pędziwiatr M; Pereira BM; Ponce-de-Leon A; Poulakou G; Preller J; Pulcini C; Pupelis G; Quiodettis M; Rawson TM; Reis T; Rems M; Rizoli S; Roberts J; Pereira NR; Rodríguez-Baño J; Sakakushev B; Sanders J; Santos N; Sato N; Sawyer RG; Scarpelini S; Scoccia L; Shafiq N; Shelat V; Sifri CD; Siribumrungwong B; Søreide K; Soto R; de Souza HP; Talving P; Trung NT; Tessier JM; Tumbarello M; Ulrych J; Uranues S; Van Goor H; Vereczkei A; Wagenlehner F; Xiao Y; Yuan KC; Wechsler-Fördös A; Zahar JR; Zakrison TL; Zuckerbraun B; Zuidema WP; Catena F
    World J Emerg Surg; 2017; 12():34. PubMed ID: 28775763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?
    Chibabhai V; Duse AG; Perovic O; Richards GA
    S Afr Med J; 2020 Jun; 110(7):572-573. PubMed ID: 32880323
    [No Abstract]   [Full Text] [Related]  

  • 33. Variability in antifungal stewardship strategies among Society for Healthcare Epidemiology of America (SHEA) Research Network facilities.
    Fitzpatrick MA; Albarillo F; Santarossa M; Evans CT; Suda KJ
    Infect Control Hosp Epidemiol; 2020 May; 41(5):585-589. PubMed ID: 32252846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
    Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
    J Glob Antimicrob Resist; 2021 Jun; 25():5-7. PubMed ID: 33662647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep Dive Into Gaps and Barriers to Implementation of Antimicrobial Stewardship Programs in Hospitals in Latin America.
    Fabre V; Secaira C; Cosgrove SE; Lessa FC; Patel TS; Alvarez AA; Anchiraico LM; Del Carmen Bangher M; Barberis MF; Burokas MS; Castañeda X; Colque AM; De Ascencao G; Esquivel C; Ezcurra C; Falleroni LA; Frassone N; Garzón MI; Gomez C; Gonzalez JA; Hernandez D; Laplume D; Lemir CG; Maldonado Briones H; Melgar M; Mesplet F; Martinez G; Pertuz CM; Moreno C; Nemirovsky C; Nuccetelli Y; Palacio B; Sandoval N; Vergara H; Videla H; Villamandos S; Villareal O; Viteri A; Quiros R
    Clin Infect Dis; 2023 Jul; 77(Suppl 1):S53-S61. PubMed ID: 37406044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves.
    Puzniak LA; Bauer KA; Yu KC; Watts JA; Ai C; Gupta V
    BMC Infect Dis; 2023 Feb; 23(1):117. PubMed ID: 36829137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Antimicrobial Stewardship Programs at Veterans Affairs Hospitals: Results of a Nationwide Survey.
    Chou AF; Graber CJ; Jones M; Zhang Y; Goetz MB; Madaras-Kelly K; Samore M; Kelly A; Glassman PA
    Infect Control Hosp Epidemiol; 2016 Jun; 37(6):647-54. PubMed ID: 26905338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross-sectional study of hospital antimicrobial stewardship programmes in the COVID-19 era.
    Leung V; Quirk J; Muir S; Daneman N; Schwartz KL; Langford BJ
    JAC Antimicrob Resist; 2023 Feb; 5(1):dlac134. PubMed ID: 36601552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple and feasible antimicrobial stewardship program in a neonatal intensive care unit of a Japanese community hospital.
    Kitano T; Takagi K; Arai I; Yasuhara H; Ebisu R; Ohgitani A; Kitagawa D; Oka M; Masuo K; Minowa H
    J Infect Chemother; 2019 Nov; 25(11):860-865. PubMed ID: 31109751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in antimicrobial use associated with a multifaceted antimicrobial stewardship programme in a tertiary teaching hospital in Shanghai: a segmented regression analysis.
    Liu YX; Liang C; Yang Y; Le KJ; Zhang ZL; Gu ZC; Zhong H; Lin HW; Luo HJ
    Ann Palliat Med; 2021 Jul; 10(7):7360-7369. PubMed ID: 34353033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.